Phosphorothioate backbone modification enhances aptamer-drug conjugate for pancreatic cancer therapy

FHS
July 10, 2023
6:59 pm

Pancreatic cancer is a complex and deadly solid tumor that poses significant challenges for both diagnosis and treatment.

Tracon mulls strategic options after sarcoma drug fails Phase II trial

Tracon licensed the North American rights to envafolimab from China-based Jiangsu Alphamab Biopharmaceuticals and 3D Medicines in 2019. Image Credit: TarikVision / Shutterstock. TRACON Pharmaceuticals

July 2, 2024

Nitrite analysis in pharmaceuticals: monitoring a precursor to nitrosamine

November 22, 2023

Sanofi reports sales jump for Beyfortus as RSV antibody challenger from Merck nears

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.